Parnassus Core Equity Fund sees Eli Lilly And Co. (NYSE:LLY) as a strong long-term investment due to its GLP-1 franchise and ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Jim Cramer recently talked about the market selloff and how years of profits are lost within days when panic hits the market: ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

Chilean AI-led food tech startup NotCo has unveiled a botanical GLP Booster powder that uses food as a natural Ozempic ...

By screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent unintended consequences.

More than a dozen of the country’s biggest tech investors say floats will return, there’s no AI bubble ... supply of weight-loss drugs Wegovy and Mounjaro has helped lift Eucalyptus ...

Roche & Zealand join forces on petrelintide, advancing obesity treatments with innovative amylin analogs. Find out why this ...

Economists around the world expect muted U.S. economic growth in the coming quarters, and some indicators have shown an increased likelihood of a 2025 recession in recent weeks. [ Sign up for ...

Ivim takes a comprehensive approach to obesity care and its customized patient-centric plans are carefully overseen by ...

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

Eli Lilly plans to release its diabetes and weight-loss drug, Mounjaro, in major global markets like China, India, Brazil, ...